In univariable analysis, ECOG (p < 0.0001), CD8 (p = 0.036), and CXCL13 in tumor cells (p < 0.0001) were critical prognostic markers for disease progression after treatment in PDAC (Table S2). This evidence concerns the gene CD8A and neoplasm.